Novartis AG
$123.12-1.88Valor de mercado
$272.5B
Posição global
#51
Máxima histórica
$279.6B
2026-09-02
Crescimento total
+0%
desde 2026
Market Cap Context
- Larger than 86% of the 367 companies we track (globally).
- Equivalent to 26.1% of Switzerland's GDP (2025 data).
- Just above: #50 Netflix ($274.2B)
- Just below: #52 AstraZeneca PLC ($266.0B)
- Best year: 1997 (+64%). Worst year: 2001 (-15%).
Novartis AG Financial Breakdown (FY 2025)
Source: Yahoo Finance — NOVN.SW annual filings (2025) →$56.7B revenue · $17.6B operating income · $14.0B net income
- ●Operating margin: 31.1% on $56.7B in revenue.
- ●R&D is 19.8% of revenue ($11.2B).
- ●Net income margin: 24.7% — $14.0B in profit.
- ●Free cash flow: $15.2B (26.9% of revenue).
Cost / Operating Expenses
Total operating expenses $39.0B
Total
$38.1B
Capital Expenditures
$3.9B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$15.2B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Fundamentals (TTM)
Data: Financial Modeling PrepP/E
—
EPS
—
Net margin
—
ROE
—
Dividend yield
—
Debt / Equity
—
Sobre a Novartis AG
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Histórico de valor de mercado da Novartis AG (2026–2026)
Novartis AG vs Sector Peers by Market Cap
Comparar Novartis AG
Histórico de classificação
| Ano | Valor de mercado | Posição | Variação anual |
|---|---|---|---|
| 2026 | $272.5B | #51(↑6) | +19.9% |
| 2025 | $227.3B | #57(↑6) | +28.0% |
| 2024 | $177.6B | #63(↓3) | +8.4% |
| 2023 | $163.8B | #60(↓8) | +11.9% |
| 2022 | $146.3B | #52(↑19) | +8.8% |
| 2021 | $134.5B | #71(↓10) | -0.1% |
| 2020 | $134.7B | #61(↓25) | -5.4% |
| 2019 | $142.4B | #36(↑5) | +28.5% |
| 2018 | $110.8B | #41(↑4) | +6.5% |
| 2017 | $104.0B | #45(↓4) | +16.0% |
| 2016 | $89.6B | #41(↓14) | -10.7% |
| 2015 | $100.4B | #27(↓2) | -2.9% |
| 2014 | $103.4B | #25(↑14) | +34.9% |
| 2013 | $76.6B | #39(↓2) | +29.4% |
| 2012 | $59.2B | #37(↓2) | +12.9% |
| 2011 | $52.5B | #35(↑1) | +2.7% |
| 2010 | $51.1B | #36(↓8) | +0.8% |
| 2009 | $50.7B | #28(↓6) | +13.9% |
| 2008 | $44.5B | #22(↑16) | -12.1% |
| 2007 | $50.6B | #38(↓11) | -9.5% |
| 2006 | $55.9B | #27(↓8) | +3.7% |
| 2005 | $53.9B | #19(↑6) | +23.1% |
| 2004 | $43.8B | #25(↓1) | +4.2% |
| 2003 | $42.0B | #24(↓4) | +14.0% |
| 2002 | $36.9B | #20(↑3) | -14.5% |
| 2001 | $43.1B | #23(↑3) | -15.0% |
| 2000 | $50.7B | #26(↑7) | +24.5% |
| 1999 | $40.7B | #33(↓11) | -12.0% |
| 1998 | $46.3B | #22(↓6) | +15.4% |
| 1997 | $40.1B | #16(↑4) | +63.8% |
| 1996 | $24.5B | #20(↑4) | +45.2% |
| 1995 | $16.9B | #24 |
Outras empresas do setor Saúde
Perguntas frequentes
What is Novartis AG's market cap?
Novartis AG (NOVN.SW) has a market capitalization of $272.5B, making it the #51 largest company in the world by market cap.
What was Novartis AG's highest market cap?
Novartis AG's all-time high market cap was $279.6B, reached in 2026-09-02. Its highest rank was #51 in 2026.
What sector is Novartis AG in?
Novartis AG is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in Switzerland.
How has Novartis AG's market cap changed over time?
Novartis AG has been tracked since 2026. Its market cap has grown by 0% from $272.5B in 2026 to $272.5B today.